Skip to main content

VIDC

(604) 642-6429 1177 Hornby Street, Vancouver
Cutting Edge Treatment. Cutting Edge Care. Explore Current Clinical Trials Discover Vancouver Urban Health Centre
Monday–Friday: 9 a.m.–5 p.m. Open weekdays
Resource Hub
Access Care Donate
Back to Published Work
VIDC Research
Research Paper

Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C infection in Vancouver, Canada

Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in...

Holeksa J, Magel T, Alimohammadi A, Thiam A, Yung R, Chu L, Truong D, Conway B. Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C infection in Vancouver, Canada. International Journal of Drug Policy. 2019; 17

Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in some cohorts. The aim of this study was to evaluate reinfection following successful treatment for hepatitis C virus infection in a cohort of people who inject drugs in Vancouver, Canada.

Continue Reading

View the original publication.

Access the full paper, conference material or external publication source where available.

View Original Source
Continue Exploring

Related Published Work.

View All Published Work
VIDC Research

Explore current research opportunities.

View Current Studies